Header Logo

Connection

DEBRA PALAZZI to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications DEBRA PALAZZI has written about Cost-Benefit Analysis.
DEBRA PALAZZI
Connection Strength
0.016
Cost-Benefit Analysis
  1. Prevalence of respiratory syncytial virus (RSV) risk factors and cost implications of immunoprophylaxis to infants 32 to 35 weeks gestation for health plans in the United States. Value Health. 2010 Jan-Feb; 13(1):77-86.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.